A race to develop a COVID-19 vaccine began almost the minute the coronavirus’s genetic makeup was revealed in January. Already, two companies have announced that their vaccines appear safe and about 95 percent effective (SN: 11/18/20, SN: 11/16/20). Government regulators in the United Kingdom granted permission December 2 for emergency use of a vaccine made […]

Over the years we have witnessed how natural disasters can have a significant impact on biopharmaceutical industry supply chains. For example, in 2010 a volcanic ash cloud from an eruption in Iceland caused the largest air-traffic shutdown since WWII. The earthquake and tsunami that struck Japan in 2011 caused that country a nationwide drug shortage. […]

Moderna Inc. and Covaxx Inc. are readying for delivery more than 220 million doses of their respective COVID-19 vaccines to Europe and emerging countries in newly cut deals. Moderna, of Cambridge, Mass., said it granted an option to the European Commission to buy up to 80 million additional doses of mRNA-1273 and is set to […]